TrianglePUBLICATIONS · 29685952
Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood Adv
- Publication date
- 2018 Apr 24
- First author
- Stahl M
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Stahl M
- type
- Author
- name
- DeVeaux M
- type
- Author
- name
- Montesinos P
- type
- Author
- name
- Itzykson R
- type
- Author
- name
- Ritchie EK
- type
- Author
- name
- Sekeres MA
- type
- Author
- name
- Barnard JD
- type
- Author
- name
- Podoltsev NA
- type
- Author
- name
- Brunner AM
- type
- Author
- name
- Komrokji RS
- type
- Author
- name
- Bhatt VR
- type
- Author
- name
- Al-Kali A
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Stahl M
- type
- Author
- name
- DeVeaux M
- type
- Author
- name
- Montesinos P
- type
- Author
- name
- Itzykson R
- type
- Author
- name
- Ritchie EK
- type
- Author
- name
- Sekeres MA
- type
- Author
- name
- Barnard JD
- type
- Author
- name
- Podoltsev NA
- type
- Author
- name
- Brunner AM
- type
- Author
- name
- Komrokji RS
- type
- Author
- name
- Bhatt VR
- type
- Author
- name
- Al-Kali A
- type
- Author
- bibliography ids
- nci-bib-37b870f42dfa3b7e63172899
- book metadata
- content sha256
- fec07022af1db45c1a8dd8562dfff254602a0c9da3c7207cd56d17d7160dd6f7
- document type
- citation
- dois
- 10.1182/bloodadvances.2018016121
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:29685952
- immutable id
- pubmed:29685952@fec07022af1db45c1a8dd8562dfff254602a0c9da3c7207cd56d17d7160dd6f7
- journal
- abbreviation
- Blood Adv
- issn electronic
- 2473-9537
- issn print
- 2473-9529
- issue
- 8
- name
- Blood advances
- nlm unique id
- 101698425
- pages
- 923-932
- volume
- 2
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 29685952
- provenance
- batch id
- c4c0356d060413f719c2
- provider
- NCBI PubMed ESummary
- record sha256
- ad47089e3ff28c4ca14f1e0786c2da2e5a675911da770e99b30666611c9a1e8e
- response sha256
- adeb6beaad718f060a94981fd9e96a2eaddc4f781839549cb3e53cba822117c0
- retrieved at
- 2026-09-09T23:47:33.674758+00:00
- publication date
- display
- 2018 Apr 24
- precision
- day
- year
- 2018
- publication types
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort.
Preserved source evidence · Not medical advice